Catecholamine measures for diagnosis and treatment of patients with depressive disorders.
Measurement of the catecholamine's, norepinephrine, epinephrine, metanephrine, normetanephrine, vanilmandelic acid, and 3-methoxy-4-hydroxyphenyl-glycol (MHPG) show certain statistical correlations with three clinical diagnoses. These conditions are as follows: 1) bipolar and schizo-affective depression, 2) unipolar nonendogenous depressions, and 3) schizophrenia related depressions. More specifically MHPG acts to predict which patients will require higher doses of medication, higher plasma levels, and longer treatment periods to respond to treatment.
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000175:diagnosis; D002395:Catecholamines / Q000652:urine*; D003866:Depressive Disorder / Q000175:diagnosis* / Q000188:drug therapy; D004837:Epinephrine / Q000652:urine; D006801:Humans; D008676:Metanephrine / Q000652:urine; D008734:Methoxyhydroxyphenylglycol / Q000652:urine; D009638:Norepinephrine / Q000652:urine; D009647:Normetanephrine / Q000652:urine; D012559:Schizophrenia / Q000175:diagnosis; D014642:Vanilmandelic Acid / Q000652:urine
D000929:Antidepressive Agents, Tricyclic; D002395:Catecholamines; D009647:Normetanephrine; D008676:Metanephrine; D008734:Methoxyhydroxyphenylglycol; D014642:Vanilmandelic Acid; D009638:Norepinephrine; D004837:Epinephrine